5Seifart C,Clostermann U,Seffart U,et al.Cell-specific modulation of surfactant proteins by ambroxol treatment[J].Toxicol Appl Pharmacol,2005,203(1):27-35.
6Kido H,Okumura Y,Yamada H,et al.Secreatory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential[J].Biol Chem,2004,385 (11):1029-1034.
7Malerba M,Ponticiello A,Radaeli A,et al.Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD.Double-blind,randomized,multicenter,placebo-controlled study(the AMETHIST Trial)[J].Pulm Pharmacol Ther,2004,17 (1):27-34.
3Nader N D,Knight P R,Bobela I,et al.High dose nitric oxide inhalation increases lung injury after gastric aspiration[J].Anesthesiology,1999,91:741-749.
4Lee C S,Jang Y Y,Han E S.Depressant effects of ambroxol on lipopolysaccharide-or fMLP-stimulated free radical production and granule enzyme release by alveolar macrophages[J].Pulm Pharmacol Ther,1999,12:275-284.
5Teramoto S,Suzuki M,Ohga E,et al.Effects of ambroxol on spontaneous or stimulated generation of reactive oxygen species by bronchoalveolar lavage cells harvested from patients with or without chronic obstructive pulmonary diseases[J].Pharmacology,1999,59:135-141.
6Pfeifer S,Zissel G,Kienast K,et al.Reduction of cytokine release of blood and bronchoalveolar mononuclear cells by ambroxol[J].Eur J Med Res,1997,2:129132.
7Kimoto A,Saito M,Hirano Y,et al.The effects of YM26818:1-(2dimethylaminoethyl)-1-(3,4,5-trimethoxyphenyl)urea and derivatives on pulmonary surfactant secretion and lung compliance[J].Yakugaku Zasshi,1998,118:294-300.
8Davidson B A,Knight P R,Helinski J D,et al.The role of tumor necrosis factor-alpha in the pathogenesis of aspiration pneumonitis in rats[J].Anesthesiology,1999,91:486-499.
9Nader N D,Knight P R,Thusu K,et al.Reactive oxygen species contributed to oxygen-related lung injury after acid aspiration[J].Anesth Analg,1998,87:127-133.
